Growth Metrics

Lucid Diagnostics (LUCD) Cash from Investing Activities (2021 - 2026)

Lucid Diagnostics filings provide 5 years of Cash from Investing Activities readings, the most recent being -$51000.0 for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 80.31% to -$51000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$197000.0, a 69.5% increase, with the full-year FY2025 number at -$197000.0, up 69.5% from a year prior.
  • Cash from Investing Activities hit -$51000.0 in Q4 2025 for Lucid Diagnostics, down from -$28000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$1000.0 in Q2 2021 to a low of -$2.4 million in Q2 2022.
  • Median Cash from Investing Activities over the past 5 years was -$51000.0 (2025), compared with a mean of -$317578.9.
  • Biggest five-year swings in Cash from Investing Activities: plummeted 243500.0% in 2022 and later soared 99.38% in 2023.
  • Lucid Diagnostics' Cash from Investing Activities stood at -$824000.0 in 2021, then soared by 75.36% to -$203000.0 in 2022, then increased by 13.79% to -$175000.0 in 2023, then plummeted by 48.0% to -$259000.0 in 2024, then surged by 80.31% to -$51000.0 in 2025.
  • The last three reported values for Cash from Investing Activities were -$51000.0 (Q4 2025), -$28000.0 (Q3 2025), and -$25000.0 (Q2 2025) per Business Quant data.